MedTrace Logo

Study Evaluating the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults

NCT07110896 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 236

Last updated 2026-03-11

No results posted yet for this study

Summary

To assess the effect of 3 months of daily consumption of a postbiotic (inactivated lactic acid bacteria) Humiome® Post LB on stress measured by the Depression Anxiety Stress Scale-21 (DASS-21) adjusted on baseline in study participants when compared to placebo

Conditions

  • Healthy Aging

Interventions

DIETARY_SUPPLEMENT

Humiome Post LB (Postbiotic)

Heat-inactivated lactobacilli with fermented medium (a postbiotic) in 340mg powder format

DIETARY_SUPPLEMENT

Placebo

Microcrystalline cellulose, 340mg powder format

Sponsors & Collaborators

  • Analyze & Realize

    collaborator NETWORK

  • dsm-firmenich Switzerland AG

    lead INDUSTRY

Principal Investigators

  • Mehdi Sadaghian, PhD · dsm-firmenich Switzerland AG

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2026-10-31
Completion
2026-11-30

Countries

  • France
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07110896 on ClinicalTrials.gov